Connect
MJA
MJA

In Other Journals

Tanya Grassi
Med J Aust 2007; 186 (4): 212.
Published online: 19 February 2007

Growth hormone (GH) is unlikely to be useful as an anti-ageing therapy in the healthy elderly, according to a US-based systematic review. Use of GH as an anti-ageing agent is widespread, due to reports in the mainstream and medical literature, but after conducting a systematic analysis, researchers concluded that the practice is not supported by the evidence base. Although people using GH show changes in body composition, such as increased lean body mass and decreased fat mass, those treated with GH experience adverse events such as soft tissue oedema, carpal tunnel syndrome, and gynaecomastia at significantly higher rates. The researchers acknowledged the limitations in the review, including the lack of robust, large, randomised controlled trials studying the effects of GH in this population, but concluded that “GH cannot be recommended for use among the healthy elderly”.

  • Tanya Grassi


Correspondence: 

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.